Medicare Part D

Small Doses: Pharmacy News Featuring Opioids, Ketamine, and More
Small Doses: Pharmacy News Featuring Opioids, Ketamine, and MoreSmall Doses is news for pharmacists in a way that works for you.
Pharmacists to Descend on Washington
Pharmacists to Descend on WashingtonDIR fees and health-care reform will lead pharmacists’ legislative concerns.
Four ways Medicare Part D has affected costs for diabetic patientsUnderstand Medicare Part D’s design and its coverage gap to offer the most affordable prescription drug options for patients.
Drug costs chief concern of Medicare recipientsMedicare Part D recipients are most concerned about prescription drug costs—and their co-pay costs are the most important factor when choosing a pharmacy.
Medicare Part D patients not taking blood pressure meds correctlyExpert offers specific actions for managed care execs to take
Every pharmacist has them — and so does every teacherWhat do pharmacists and teachers — and an awful lot of other people — have in common?
Medicare drug pricing debate heats upA senator is investigating whether Medicare's prescription drug benefit is vulnerable to manipulation by pharmaceutical companies after an exclusive Associated Press report showed that Medicare’s spending on certain drugs soared by 85 percent.
Medicare drug costs should parallel those of MedicaidMedicare should have the same authority that Medicaid has to negotiate drug prices directly with manufacturers. If the government can do it for one program, it can do it for another.
How Walmart plans to save on genericsWalmart has decided to put all its eggs in a really big basket.
Biosimilars pose problems for Medicare beneficiaries
Biosimilars pose problems for Medicare beneficiariesSurprisingly, Medicare beneficiaries are likely to pay much more for biosimilars than the referenced brand medication, according to a new report.